1. Home
  2. PARK vs PYPD Comparison

PARK vs PYPD Comparison

Compare PARK & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PARK

Park Dental Partners Inc.

N/A

Current Price

$17.17

Market Cap

70.6M

Sector

Health Care

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.22

Market Cap

77.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PARK
PYPD
Founded
1972
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.6M
77.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PARK
PYPD
Price
$17.17
$4.22
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
26.9K
48.4K
Earning Date
05-08-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.06
N/A
Revenue Next Year
$6.17
N/A
P/E Ratio
$6.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.29
$2.30
52 Week High
$21.60
$5.12

Technical Indicators

Market Signals
Indicator
PARK
PYPD
Relative Strength Index (RSI) 47.18 45.78
Support Level $14.41 $4.01
Resistance Level $21.33 $4.38
Average True Range (ATR) 1.26 0.18
MACD -0.29 0.01
Stochastic Oscillator 29.87 25.60

Price Performance

Historical Comparison
PARK
PYPD

About PARK Park Dental Partners Inc.

Park Dental Partners Inc is a dental resource organization (DRO) operating through its subsidiary. It Provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30-years, with automatic 5-year renewals.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: